David Roberts's most recent trade in Anteris Technologies Global Corp. was a trade of 17,580 Common Stock done . Disclosure was reported to the exchange on June 7, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Anteris Tech Global Corp | David B. Roberts | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2026 | 17,580 | 17,580 | - | - | Common Stock | |
| Anteris Tech Global Corp | David B. Roberts | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2026 | 17,580 | 35,162 | - | - | Restricted Stock Units | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 4 | 8 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 3 | 15 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 3 | 26 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 3 | 28 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 2 | 14 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 1 | 23 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 1 | 22 | - | - | Dividend Equivalent Rights | |
| HNI Corp | David M. Roberts | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2026 | 4,786 | 11,480 (0%) | 0% | 0 | Common Stock | |
| HNI Corp | David M. Roberts | Director | Grant, award, or other acquisition of securities at price $ 29.25 per share. | 19 May 2026 | 427 | 11,907 (0%) | 0% | 29.3 | 12,490 | Common Stock |
| SPX Tech Inc | David A. Roberts | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2026 | 754 | 41,347 (0%) | 0% | - | Common Stock | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2026 | 3 | 3 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2026 | 3 | 24 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2026 | 2 | 23 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2026 | 2 | 11 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2026 | 2 | 11 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2026 | 1 | 21 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2026 | 1 | 20 | - | - | Dividend Equivalent Rights | |
| Verra Mobility Corp (Class A) | David M. Roberts | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2026 | 93,362 | 882,089 (0%) | 0% | 0 | Class A Common Stock | |
| Verra Mobility Corp (Class A) | David M. Roberts | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.70 per share. | 16 Mar 2026 | 39,520 | 842,569 (0%) | 0% | 16.7 | 659,984 | Class A Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Sale of securities on an exchange or to another person at price $ 107.70 per share. | 11 Mar 2026 | 3,311 | 14,667 (0%) | 0% | 107.7 | 356,586 | Common Stock |
| Verra Mobility Corp (Class A) | David M. Roberts | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 85,329 | 85,329 | - | - | Restricted Stock Units | |
| Verra Mobility Corp (Class A) | David M. Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 16,106 | 787,067 (0%) | 0% | 0 | Class A Common Stock | |
| Verra Mobility Corp (Class A) | David M. Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 16,106 | 0 | - | - | Restricted Stock Units | |
| Verra Mobility Corp (Class A) | David M. Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 15,845 | 777,668 (0%) | 0% | 0 | Class A Common Stock | |
| Verra Mobility Corp (Class A) | David M. Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 15,845 | 15,845 | - | - | Restricted Stock Units | |
| Verra Mobility Corp (Class A) | David M. Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 14,699 | 794,949 (0%) | 0% | 0 | Class A Common Stock | |
| Verra Mobility Corp (Class A) | David M. Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 14,699 | 44,098 | - | - | Restricted Stock Units | |
| Verra Mobility Corp (Class A) | David M. Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 13,112 | 767,525 (0%) | 0% | 0 | Class A Common Stock | |
| Verra Mobility Corp (Class A) | David M. Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 13,112 | 26,224 | - | - | Restricted Stock Units | |
| Verra Mobility Corp (Class A) | David M. Roberts | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.79 per share. | 01 Mar 2026 | 6,817 | 780,250 (0%) | 0% | 16.8 | 114,457 | Class A Common Stock |
| Verra Mobility Corp (Class A) | David M. Roberts | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.70 per share. | 01 Mar 2026 | 6,707 | 770,961 (0%) | 0% | 16.7 | 112,007 | Class A Common Stock |
| Verra Mobility Corp (Class A) | David M. Roberts | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.79 per share. | 01 Mar 2026 | 6,222 | 788,727 (0%) | 0% | 16.8 | 104,467 | Class A Common Stock |
| Verra Mobility Corp (Class A) | David M. Roberts | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.71 per share. | 01 Mar 2026 | 5,702 | 761,823 (0%) | 0% | 16.7 | 95,280 | Class A Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Sale of securities on an exchange or to another person at price $ 106.80 per share. | 26 Feb 2026 | 8,464 | 17,979 (0%) | 0% | 106.8 | 903,958 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 1,514 | 26,444 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 146 | 26,590 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 113.69 per share. | 26 Feb 2026 | 134 | 26,456 (0%) | 0% | 113.7 | 15,234 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 113.69 per share. | 26 Feb 2026 | 13 | 26,443 (0%) | 0% | 113.7 | 1,478 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 3 | 26,593 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 3 | 9 | - | - | Dividend Equivalent Rights | |
| HNI Corp | David M. Roberts | Director | Grant, award, or other acquisition of securities at price $ 50.14 per share. | 18 Feb 2026 | 209 | 6,694 (0%) | 0% | 50.1 | 10,479 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.29 per share. | 05 Feb 2026 | 2,672 | 24,923 (0%) | 0% | 37.3 | 99,639 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2026 | 2,672 | 0 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2026 | 7 | 14,054 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.57 per share. | 05 Feb 2026 | 7 | 24,930 (0%) | 0% | 48.6 | 340 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.00 per share. | 11 Dec 2025 | 302 | 22,251 (0%) | 0% | 84 | 25,368 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.00 per share. | 11 Dec 2025 | 302 | 22,535 (0%) | 0% | 84 | 25,368 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.36 per share. | 11 Dec 2025 | 297 | 22,819 (0%) | 0% | 83.4 | 24,758 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2025 | 25 | 23,116 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2025 | 25 | 0 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2025 | 18 | 22,837 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2025 | 18 | 19 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2025 | 18 | 19 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2025 | 18 | 22,553 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2025 | 10,400 | 10,400 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2025 | 1,694 | 23,091 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.93 per share. | 08 Dec 2025 | 230 | 21,591 (0%) | 0% | 82.9 | 19,074 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.93 per share. | 08 Dec 2025 | 205 | 21,397 (0%) | 0% | 82.9 | 17,001 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 11 | 21,602 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 11 | 21 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 9 | 20 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 9 | 21,821 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.53 per share. | 04 Dec 2025 | 99 | 21,822 (0%) | 0% | 84.5 | 8,368 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.50 per share. | 04 Dec 2025 | 10 | 21,812 (0%) | 0% | 84.5 | 845 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2025 | 4 | 32 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2025 | 4 | 29 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2025 | 3 | 21,921 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2025 | 3 | 9 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2025 | 3 | 12 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2025 | 3 | 37 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2025 | 3 | 37 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2025 | 1 | 26 | - | - | Dividend Equivalent Rights | |
| Anteris Tech Global Corp | David B. Roberts | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2025 | 52,742 | 52,742 | - | - | Restricted Stock Units | |
| Anteris Tech Global Corp | David B. Roberts | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2025 | 13,821 | 13,821 | - | - | Restricted Stock Units | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.68 per share. | 02 Dec 2025 | 107 | 21,918 (0%) | 0% | 83.7 | 8,954 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2025 | 15 | 0 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2025 | 15 | 22,025 (0%) | 0% | 0 | Common Stock | |
| HNI Corp | David M. Roberts | Director | Grant, award, or other acquisition of securities at price $ 39.78 per share. | 06 Nov 2025 | 263 | 6,485 (0%) | 0% | 39.8 | 10,462 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2025 | 4 | 27 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2025 | 3 | 25 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2025 | 2 | 34 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2025 | 2 | 34 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2025 | 2 | 9 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2025 | 1 | 25 | - | - | Dividend Equivalent Rights | |
| HNI Corp | David M. Roberts | Director | Grant, award, or other acquisition of securities at price $ 44.61 per share. | 12 Aug 2025 | 235 | 6,222 (0%) | 0% | 44.6 | 10,483 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.29 per share. | 11 Aug 2025 | 6,713 | 24,689 (0%) | 0% | 37.3 | 250,328 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 6,713 | 2,672 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Sale of securities on an exchange or to another person at price $ 92.35 per share. | 11 Aug 2025 | 6,713 | 17,976 (0%) | 0% | 92.4 | 619,978 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 3,979 | 9,385 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.29 per share. | 11 Aug 2025 | 3,979 | 21,955 (0%) | 0% | 37.3 | 148,377 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Sale of securities on an exchange or to another person at price $ 92.53 per share. | 11 Aug 2025 | 3,718 | 18,360 (0%) | 0% | 92.5 | 344,040 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Sale of securities on an exchange or to another person at price $ 91.55 per share. | 11 Aug 2025 | 384 | 17,976 (0%) | 0% | 91.5 | 35,155 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 123 | 0 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.48 per share. | 11 Aug 2025 | 123 | 22,078 (0%) | 0% | 35.5 | 4,364 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 5 | 22 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 4 | 22 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 3 | 6 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 3 | 32 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 3 | 31 | - | - | Dividend Equivalent Rights |